ICG Life Sciences

Venture Capital

Part of Intermediate Capital Group

Growth-stage life sciences investment strategy of ICG, backing innovative biotech companies with significant unmet patient needs.

London, United Kingdom · 4+ investments · 4 portfolio companies

Growth
Biotech
Life Sciences
Headquarters
London, United Kingdom
Founded
2021
Website
icgam.com
Portfolio Companies
4
Total Investments
4
Last Investment
Jun 2026
Geographic Focus
United Kingdom, United States

Investment Thesis

Builds portfolio of 12-15 innovative growth-stage biotech companies addressing significant unmet clinical needs.

ICG Life Sciences is a Venture Capital firm based in London, United Kingdom. It has made 4 investments in Biotech and Life Sciences, including F2G, Grey Wolf Therapeutics and Draig Therapeutics.

Portfolio4

Co-investors24

Sign up to view co-investors

24 co-investors across 28 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×16 · Private Equity ×4 · Corporate VC ×3 · 8 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

ICG Life Sciences on Indexed.vc
<a href="https://indexed.vc/investors/icg-life-sciences"><img src="https://indexed.vc/api/badge/investor/icg-life-sciences" alt="ICG Life Sciences on Indexed.vc" width="260" height="76" /></a>